BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
PRKCA
,
cell-cell adhesion
,
Leukemia
,
Leukocyte
,
Biofuel
,
Fenofibrate
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
fomesafen
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
CDH1
DTWD1
ANAPC1
NT5DC1
COPS4
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP
RADAEVA_RESPONSE_TO_IFNA1_UP
SHEN_SMARCA2_TARGETS_UP
DER_IFN_ALPHA_RESPONSE_UP
FAN_OVARY_CL8_MATURE_CUMULUS_GRANULOSA_CELL_2
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Breast adenocarcinoma MCF7 cells treated with various environmental chemicals
Explore Curated Studies Results
Literature
Most Relevant Literature
Research progress on residual characteristics, ecological risk, and abatement of fomesafen in farmla…
Development of an immunoassay based on a specific antibody for the detection of diphenyl ether herbi…
Investigation of resistance mechanisms to fomesafen in Ipomoea nil from China.
Remediation of fomesafen contaminated soil by Bacillus sp. Za: Degradation pathway, community struct…
Target gene mutation and enhanced metabolism confer fomesafen resistance in an Amaranthus retroflexu…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for fomesafen
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ